Changes in Gene Expression Profiling of Apoptotic Genes in Neuroblastoma Cell Lines upon Retinoic Acid Treatment

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Celay, Jon ^a   Blanco, Idoia ^a   Lázcoz, Paula ^a   Rotinen, Mirja ^a   Castresana, Javier S ^b   Encío, Ignacio ^a  

^a PUBLIC UNIVERSITY OF NAVARRE   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOIC ACID; ALITRETINOIN; ANTINEOPLASTIC AGENT; TRANSCRIPTOME;

APOPTOSIS; ARTICLE; CELL ACTIVITY; CELL DENSITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL SURVIVAL; CIS ISOMER; CONTROLLED STUDY; ENZYME INHIBITION; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; NEUROBLASTOMA; NEUROBLASTOMA CELL; TREATMENT RESPONSE; TUMOR CELL LINE; CELL SHAPE; DRUG EFFECTS; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETICS;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL SHAPE; CELL SURVIVAL; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEUROBLASTOMA; TRANSCRIPTOME; TRETINOIN;

EID: 84877057372     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062771     Document Type: Article

References (43)

1. Morriss-Kay GM (1997) Retinoids in mammalian embryonic development. In: Sherbet GV, editor. Retinoids: their physiological function and therapeutic potential. Greenwich, CT: Jai Press Inc. 79-93.
2. Redfern CPF (1997) Molecular mechanisms of retinoid function. In: Sherbet GV, editor. Retinoids: their physiological function and therapeutic potential. Greenwich, CT: Jai Press Inc. 35-77.
3. Ponzoni M, Bocca P, Chiesa V, Decensi A, Pistoia V, et al. (1995) Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation. Cancer Res 55: 853-861.
4. Ronca F, Yee KS, Yu VC, (1999) Retinoic acid confers resistance to p53-dependent apoptosis in SH-SY5Y neuroblastoma cells by modulating nuclear import of p53. J Biol Chem 274: 18128-18134.
5. Cheung YT, Lau WK, Yu MS, Lai CS, Yeung SC, et al. (2009) Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research. Neurotoxicology 30: 127-135.
6. Matthay KK, Reynolds CP, Seeger RC, Shimada H, Adkins ES, et al. (2009) Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study. J Clin Oncol 27: 1007-1013.
7. Futami H, Sakai R, (2010) All-trans retinoic acid downregulates ALK in neuroblastoma cell lines and induces apoptosis in neuroblastoma cell lines with activated ALK. Cancer Lett 297: 220-225.
8. Voigt A, Zintl F, (2003) Effects of retinoic acid on proliferation, apoptosis, cytotoxicity, migration, and invasion of neuroblastoma cells. Med Pediatr Oncol 40: 205-213.
9. Fang Y, Zhou X, Lin M, Ying M, Luo P, et al. (2011) Inhibition of all-trans-retinoic acid-induced proteasome activation potentiates the differentiating effect of retinoid in acute myeloid leukemia cells. Mol Carcinog 50: 24-35.
10. Park JR, Villablanca JG, London WB, Gerbing RB, Haas-Kogan D, et al. (2009) Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: a report from the Children's Oncology Group. Pediatr Blood Cancer 52: 44-50.
11. van Noesel MM, Versteeg R, (2004) Pediatric neuroblastomas: genetic and epigenetic 'danse macabre'. Gene 325: 1-15.
12. Irving H, Lovat PE, Hewson QC, Malcolm AJ, Pearson AD, et al. (1998) Retinoid-induced differentiation of neuroblastoma: comparison between LG69, an RXR-selective analogue and 9-cis retinoic acid. Eur J Cancer 34: 111-117.
13. Lovat PE, Irving H, Annicchiarico-Petruzzelli M, Bernassola F, Malcolm AJ, et al. (1997) Retinoids in neuroblastoma therapy: distinct biological properties of 9-cis- and all-trans-retinoic acid. Eur J Cancer 33: 2075-2080.
14. Lovat PE, Irving H, Annicchiarico-Petruzzelli M, Bernassola F, Malcolm AJ, et al. (1997) Apoptosis of N-type neuroblastoma cells after differentiation with 9-cis-retinoic acid and subsequent washout. J Natl Cancer Inst 89: 446-452.
15. Lovat PE, Irving H, Malcolm AJ, Pearson AD, Redfern CP, (1997) 9-cis retinoic acid-a better retinoid for the modulation of differentiation, proliferation and gene expression in human neuroblastoma. J Neurooncol 31: 85-91.
16. Gaetano C, Matsumoto K, Thiele CJ, (1991) Retinoic acid resistant neuroblastoma cells and the expression of insulin-like growth factor-II. Prog Clin Biol Res 366: 165-172.
17. Borriello A, Roberto R, Della Ragione F, Iolascon A, (2002) Proliferate and survive: cell division cycle and apoptosis in human neuroblastoma. Haematologica 87: 196-214.
18. Wajant H, Pfizenmaier K, Scheurich P, (2002) TNF-related apoptosis inducing ligand (TRAIL) and its receptors in tumor surveillance and cancer therapy. Apoptosis. 7: 449-459.
19. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS Jr, (1998) NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281: 1680-1683.
20. Chu ZL, McKinsey TA, Liu L, Gentry JJ, Malim MH, et al. (1997) Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control. Proc Natl Acad Sci USA 94: 10057-10062.
21. Lázcoz P, Muñoz J, Nistal M, Pestaña A, Encío I, et al. (2006) Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma. BMC Cancer 6: 254.
22. Matsumoto M, Akiyama T, Miyatake S, Oda Y, Kikuchi H, et al. (1989) Expression of proto-oncogene products during drug-induced differentiation of a neuroblastoma cell line SK-N-DZ. Acta Neuropathol 79: 217-221.
23. Sarkanen JR, Nykky J, Siikanen J, Selinummi J, Ylikomi T, et al. (2007) Cholesterol supports the retinoic acid-induced synaptic vesicle formation in differentiating human SH-SY5Y neuroblastoma cells. J Neurochem 102: 1941-1952.
24. Redfern CP, Lovat PE, Malcolm AJ, Pearson AD, (1995) Gene expression and neuroblastoma cell differentiation in response to retinoic acid: differential effects of 9-cis and all-trans retinoic acid. Eur J Cancer 31A: 486-494.
25. Bunone G, Borrello MG, Picetti R, Bongarzone I, Peverali FA, et al. (1995) Induction of RET proto-oncogene expression in neuroblastoma cells precedes neuronal differentiation and is not mediated by protein synthesis. Exp Cell Res 217: 92-99.
26. Angrisano T, Sacchetti S, Natale F, Cerrato A, Pero R, et al. (2011) Chromatin and DNA methylation dynamics during retinoic acid-induced RET gene transcriptional activation in neuroblastoma cells. Nucleic Acids Res 39: 1993-2006.
27. Oppenheimer O, Cheung NK, Gerald WL, (2007) The RET oncogene is a critical component of transcriptional programs associated with retinoic acid-induced differentiation in neuroblastoma. Mol Cancer Ther 6: 1300-1309.
28. Westermark UK, Wilhelm M, Frenzel A, Henriksson MA, (2011) The MYCN oncogene and differentiation in neuroblastoma. Semin Cancer Biol 21: 256-266.
29. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408.
30. Chen L, Willis SN, Wei A, Smith BJ, Fletcher JI, et al. (2005) Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 17: 393-403.
31. Uren AG, Pakusch M, Hawkins CJ, Puls KL, Vaux DL, (1996) Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors. Proc Natl Acad Sci USA 93: 4974-4978.
32. Lamkanfi M, Kalai M, Saelens X, Declercq W, Vandenabeele P, (2004) Caspase-1 activates nuclear factor of the kappa-enhancer in B cells independently of its enzymatic activity. J Biol Chem 279: 24785-24793.
33. Furusu A, Nakayama K, Xu Q, Konta T, Kitamura M, (2007) MAP kinase-dependent, NF-kappaB-independent regulation of inhibitor of apoptosis protein genes by TNF-alpha. J Cell Physiol 210: 703-710.
34. Bégaud-Grimaud G, Battu S, Lazcoz P, Castresana JS, Jauberteau MO, et al. (2007) Study of the phenotypic relationship in the IMR-32 human neuroblastoma cell line by sedimentation field flow fractionation. Int J Oncol 31: 883-892.
35. Dufner A, Pownall S, Mak TW, (2006) Caspase recruitment domain protein 6 is a microtubule-interacting protein that positively modulates NF-kappaB activation. Proc Natl Acad Sci USA 103: 988-993.
36. Stehlik C, Hayashi H, Pio F, Godzik A, Reed JC, (2003) CARD6 is a modulator of NF-kappa B activation by Nod1- and Cardiak-mediated pathways. J Biol Chem 278: 31941-31949.
37. Yeh PY, Kuo SH, Yeh KH, Chuang SE, Hsu CH, et al. (2006) A pathway for tumor necrosis factor-alpha-induced Bcl10 nuclear translocation. Bcl10 is up-regulated by NF-kappaB and phosphorylated by Akt1 and then complexes with Bcl3 to enter the nucleus. J Biol Chem 281: 167-175.
38. Brown KD, Hostager BS, Bishop GA, (2002) Regulation of TRAF2 signaling by self-induced degradation. J Biol Chem 277: 19433-19438.
39. Kim GM, Xu J, Xu J, Song SK, Yan P, et al. (2001) Tumor necrosis factor receptor deletion reduces nuclear factor-kappaB activation, cellular inhibitor of apoptosis protein 2 expression, and functional recovery after traumatic spinal cord injury. J Neurosci 21: 6617-6625.
40. Borysenko CW, García-Palacios V, Griswold RD, Li Y, Iyer AK, et al. (2006) Death receptor-3 mediates apoptosis in human osteoblasts under narrowly regulated conditions. J Cell Physiol 209: 1021-1028.
41. Wen L, Zhuang L, Luo X, Wei P, (2003) TL1A-induced NF-kappaB activation and c-IAP2 production prevent DR3-mediated apoptosis in TF-1 cells. J Biol Chem 278: 39251-39258.
42. Nordström EA, Rydén M, Backlund EC, Dahlman I, Kaaman M, et al. (2005) A human-specific role of cell death-inducing DFFA (DNA fragmentation factor-alpha)-like effector A (CIDEA) in adipocyte lipolysis and obesity. Diabetes 54: 1726-1734.
43. Mercader J, Madsen L, Felipe F, Palou A, Kristiansen K, et al. (2007) All-trans retinoic acid increases oxidative metabolism in mature adipocytes. Cell Physiol Biochem 20: 1061-1072.